X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11400) 11400
Newsletter (289) 289
Newspaper Article (96) 96
Magazine Article (95) 95
Transcript (27) 27
Publication (11) 11
Book / eBook (6) 6
Book Chapter (6) 6
Reference (4) 4
Book Review (2) 2
Dissertation (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10552) 10552
antirheumatic agents - adverse effects (6358) 6358
antirheumatic agents - therapeutic use (6273) 6273
female (6221) 6221
arthritis, rheumatoid - drug therapy (6069) 6069
rheumatology (5881) 5881
male (5198) 5198
rheumatoid arthritis (4808) 4808
middle aged (4796) 4796
adult (3709) 3709
treatment outcome (3317) 3317
aged (3138) 3138
methotrexate (2407) 2407
tumor necrosis factor-alpha - antagonists & inhibitors (2164) 2164
arthritis (2110) 2110
antirheumatic agents - administration & dosage (2079) 2079
infliximab (1976) 1976
etanercept (1881) 1881
therapy (1830) 1830
antirheumatic agents (1798) 1798
double-blind (1729) 1729
rheumatoid factor (1723) 1723
rheumatoid-arthritis (1638) 1638
methotrexate - therapeutic use (1586) 1586
drug therapy (1584) 1584
drug therapy, combination (1542) 1542
care and treatment (1486) 1486
antibodies, monoclonal - adverse effects (1376) 1376
methotrexate - adverse effects (1362) 1362
antibodies, monoclonal - therapeutic use (1345) 1345
risk factors (1225) 1225
efficacy (1183) 1183
medicine & public health (1143) 1143
severity of illness index (1126) 1126
adalimumab (1124) 1124
disease (1079) 1079
safety (1024) 1024
pharmacology & pharmacy (959) 959
modifying antirheumatic drugs (935) 935
research (934) 934
retrospective studies (872) 872
adolescent (847) 847
patients (835) 835
arthritis, rheumatoid - immunology (809) 809
time factors (783) 783
abridged index medicus (759) 759
immunoglobulin g - adverse effects (759) 759
arthritis, rheumatoid - complications (753) 753
tumor necrosis factor-tnf (739) 739
immunology (731) 731
double-blind method (726) 726
medicine, general & internal (717) 717
internal medicine (697) 697
methotrexate - administration & dosage (696) 696
risk (694) 694
health aspects (693) 693
receptors, tumor necrosis factor - therapeutic use (688) 688
immunoglobulin g - therapeutic use (684) 684
analysis (682) 682
arthritis, rheumatoid - diagnosis (680) 680
animals (673) 673
clinical trials (659) 659
rituximab (640) 640
dosage and administration (634) 634
follow-up studies (634) 634
inflammation (615) 615
dose-response relationship, drug (611) 611
tumor necrosis factor (604) 604
studies (602) 602
drugs (593) 593
young adult (592) 592
disease-activity (589) 589
aged, 80 and over (584) 584
medical research (575) 575
prospective studies (575) 575
child (572) 572
arthritis, psoriatic - drug therapy (570) 570
rheumatic diseases - drug therapy (549) 549
antirheumatic agents - pharmacology (547) 547
drug dosages (546) 546
antibodies, monoclonal, humanized - therapeutic use (535) 535
immunosuppressive agents - therapeutic use (530) 530
complications and side effects (521) 521
antibodies, monoclonal, humanized (513) 513
arthritis, rheumatoid - physiopathology (512) 512
arthritis, juvenile - drug therapy (492) 492
drug administration schedule (492) 492
psoriasis (489) 489
placebo-controlled trial (486) 486
biological products - therapeutic use (484) 484
immunosuppressive agents - adverse effects (481) 481
trial (479) 479
usage (476) 476
medicine, experimental (473) 473
spondylitis, ankylosing - drug therapy (466) 466
disease progression (463) 463
remission induction (460) 460
antibodies, monoclonal, humanized - adverse effects (457) 457
anti-inflammatory agents, non-steroidal - therapeutic use (455) 455
randomized controlled trials as topic (448) 448
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11138) 11138
German (330) 330
Japanese (203) 203
French (134) 134
Spanish (104) 104
Italian (52) 52
Portuguese (41) 41
Russian (37) 37
Danish (28) 28
Chinese (21) 21
Dutch (19) 19
Swedish (19) 19
Polish (14) 14
Norwegian (12) 12
Finnish (7) 7
Czech (6) 6
Hungarian (6) 6
Croatian (5) 5
Romanian (5) 5
Hebrew (4) 4
Lithuanian (2) 2
Ukrainian (2) 2
Korean (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Rheumatology (Oxford, England), ISSN 1462-0332, 2016, Volume 56, Issue 3, pp. kew442 - 425
Journal Article
BMC musculoskeletal disorders, ISSN 1471-2474, 2008, Volume 9, Issue 1, pp. 165 - 165
Background: Symptomatic slow-acting drugs (SYSADOA) have been largely studied over the last decade. The objective of this study is to prepare a document... 
CHONDROITIN SULFATE | OF-RHEUMATOLOGY RECOMMENDATIONS | INTRAARTICULAR HYALURONIC-ACID | EULAR-STANDING-COMMITTEE | TASK-FORCE | GLUCOSAMINE SULFATE | HIP OSTEOARTHRITIS | DOUBLE-BLIND | RHEUMATOLOGY | ORTHOPEDICS | KNEE OSTEOARTHRITIS | AVOCADO/SOYBEAN UNSAPONIFIABLES | Outcome Assessment (Health Care) - methods | Clinical Trials as Topic - statistics & numerical data | Thiophenes - adverse effects | Antirheumatic Agents - administration & dosage | Humans | Anthraquinones - administration & dosage | Thiophenes - administration & dosage | Osteoarthritis - drug therapy | Calcitonin - administration & dosage | Plant Extracts - administration & dosage | Glucosamine - adverse effects | Chondroitin Sulfates - adverse effects | Anthraquinones - adverse effects | Etidronic Acid - adverse effects | Calcitonin - adverse effects | Antirheumatic Agents - adverse effects | Risedronate Sodium | Hyaluronic Acid - adverse effects | Etidronic Acid - analogs & derivatives | Etidronic Acid - administration & dosage | Hyaluronic Acid - administration & dosage | Organometallic Compounds - adverse effects | Glucosamine - administration & dosage | Chondroitin Sulfates - administration & dosage | Organometallic Compounds - administration & dosage | Plant Extracts - adverse effects | Glucosamine | Research | Hyaluronic acid | Drug therapy | Osteoarthritis | Chondroitin | Index Medicus
Journal Article
Pharmaceutical Biology, ISSN 1744-5116, 2012, Volume 50, Issue 8, pp. 1053 - 1061
...; it possesses favorable effects against autoimmune diseases, especially rheumatoid arthritis (RA). A great number of investigations have been done on SA in the last decade, but they are usually scattered across various publications... 
Sinomenine | immune system | cardiovascular system | nervous system | adaptogen | Cardiovascular system | Nervous system | Adaptogen | Immune system | ABILITY IN-VITRO | MORPHINANE ALKALOIDS | ACTIVATION | SPINAL-CORD | PAEONIFLORIN | RAT MODEL | PLANT SCIENCES | TISSUE DISTRIBUTION | PHARMACOLOGY & PHARMACY | MEDICAL LABORATORY TECHNOLOGY | NF-KAPPA-B | CELL | EXPRESSION | Humans | Drugs, Chinese Herbal - pharmacology | Anti-Inflammatory Agents - adverse effects | Neurotransmitter Agents - pharmacology | Alkaloids - analysis | Anti-Inflammatory Agents - therapeutic use | Antirheumatic Agents - adverse effects | Antirheumatic Agents - pharmacology | Drugs, Chinese Herbal - therapeutic use | Morphinans - adverse effects | Morphinans - pharmacology | Drugs, Chinese Herbal - adverse effects | Antirheumatic Agents - therapeutic use | Morphinans - therapeutic use | Sinomenium - chemistry | Anti-Inflammatory Agents - pharmacology | Morphinans - analysis | Cardiovascular Agents - pharmacology | Cardiovascular Agents - therapeutic use | Ethnopharmacology | Neurotransmitter Agents - chemistry | Animals | Anti-Inflammatory Agents - chemistry | Neurotransmitter Agents - therapeutic use | Drugs, Chinese Herbal - chemistry | Neurotransmitter Agents - adverse effects | Antirheumatic Agents - chemistry | Cardiovascular Agents - adverse effects | Cardiovascular Agents - chemistry
Journal Article
Pharmacological reviews, ISSN 1521-0081, 2015, Volume 67, Issue 2, pp. 280 - 309
The human immune system involves highly complex and coordinated processes in which small proteins named cytokines play a key role. Cytokines have been... 
TUMOR-NECROSIS-FACTOR | MODIFYING ANTIRHEUMATIC DRUGS | COLONY-STIMULATING FACTOR | JUVENILE IDIOPATHIC ARTHRITIS | SEVERE PLAQUE PSORIASIS | ANTI-TNF THERAPY | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | LONG-TERM TREATMENT | ACTIVE ANKYLOSING-SPONDYLITIS | INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY | Drugs, Investigational - adverse effects | Interleukin-6 - antagonists & inhibitors | Humans | Crohn Disease - metabolism | Drugs, Investigational - therapeutic use | Spondylitis, Ankylosing - immunology | Arthritis, Rheumatoid - metabolism | Anti-Inflammatory Agents - adverse effects | Arthritis, Rheumatoid - drug therapy | Arthritis, Psoriatic - drug therapy | Psoriasis - metabolism | Anti-Inflammatory Agents - therapeutic use | Antirheumatic Agents - adverse effects | Interleukin-1 - antagonists & inhibitors | Interleukin-6 - metabolism | Arthritis, Psoriatic - metabolism | Antirheumatic Agents - therapeutic use | Psoriasis - immunology | Interleukin-1 - metabolism | Molecular Targeted Therapy - adverse effects | Psoriasis - drug therapy | Cytokines - metabolism | Spondylitis, Ankylosing - drug therapy | Tumor Necrosis Factors - metabolism | Spondylitis, Ankylosing - metabolism | Crohn Disease - immunology | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Arthritis, Psoriatic - immunology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Models, Biological | Crohn Disease - drug therapy | Cytokines - antagonists & inhibitors | Arthritis, Rheumatoid - immunology | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2014, Volume 70, Issue 1, pp. 168 - 177
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 16, pp. 1537 - 1550
Journal Article
Journal Article
by Fleischmann, Roy and Mysler, Eduardo and Hall, Stephen and Kivitz, Alan J and Moots, Robert J and Luo, Zhen and DeMasi, Ryan and Soma, Koshika and Zhang, Richard and Takiya, Liza and Tatulych, Svitlana and Mojcik, Christopher and Krishnaswami, Sriram and Menon, Sujatha and Smolen, Josef S and Adams, Luthando and Ally, Mahmood M and du Plooy, Maria C and Louw, Ingrid C and Nayiager, Savithree and Nel, Christoffel B and Nel, Debra and Reuter, Helmuth and Soloman, Ahmed S and Spargo, Catherine E and Rischmueller, Maureen and Sharma, Shunil D and Will, Robert K and Youssef, Peter P and Arroyo, Caroline and Baes, Rosario P and Dulos, Roger B and Hao, Llewellyn T and Lanzon, Allan E and Lichauco, Juan Javier T and Mangubat, Jill H and Ramiterre, Edgar B and Reyes, Bernadette Heizel M and Tan, Perry P and Choe, Jung-Yoon and Kang, Young Mo and Kwon, Seong Ryul and Lee, Sang-Heon and Lee, Shin-Seok and Yoo, Dae-Hyun and Lin, Hsiao-Yi and Luo, Shue-Fen and Tsai, Shih-Tzu and Tsai, Wen-Chan and Tseng, Jui-Cheng and Wei, Cheng-Chung C and Asavatanabodee, Paijit and Nantiruj, Kanokrat and Nilganuwong, Surasak and Uea-Areewongsa, Parichat and Majstorovic, Ljubinka Bozic and Bacic, Suada Mulic and Batalov, Anastas Z and Georgieva-Slavcheva, Gabriela and Mihailova, Mariyana and Nikolov, Nikolay G and Penev, Dimitar P and Spasov, Yuliy A and Stanimirova, Krasimira and Todorov, Stoyan and Toncheva, Antoaneta R and Yordanova, Nadezhda and Mosterova, Zdenka and Novosad, Libor and Prochazkova, Leona and Stehlikova, Helena and Stejfova, Zuzana and Kiseleva, Natalia and Pank, Lea and Savi, Triin and Alexandra, Balbir-Gurman and Amital, Howard and Mevorach, Dror and Rosner, Itzhak A and Mihailova, Anna and Stumbra-Stumberga, Evija and Basijokiene, Vida and Lietuvininkiene, Virginija and Unikiene, Dalia and Brzezicki, Jan and Dudek, Anna M and Glowacka-Kulesz, Maria B and Grabowicz-Wasko, Barbara and Hajduk-Kubacka, Sabina and Hilt, Joanna and Hrycaj, Pawel and Jeka, Slawomir and Kolasa, Renata and Krogulec, Marek and Mastalerz, Hanna and Olak-Popko, Anna and Owczarek, Elzbieta and Ruzga, Zofia and Walczak, Alina and Ancuta, Codrina I and ... and ORAL Strategy investigators and ORAL Strategy Investigators
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | JANUS KINASE INHIBITOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PLUS METHOTREXATE | AMERICAN-COLLEGE | OPEN-LABEL | COMBINATION | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Evidence-based medicine | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages
Journal Article